CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 54 enrolled
Drug / intervention
Methadone +1 moredrug
Likely dose
Methadone 60 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00879996
NCT00879996Phase 4Completed
CompareCT.gov

A Randomized Controlled Trial Comparing Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients

State University of New York at Buffalo·interventional·Posted Apr 13, 2009·Updated Aug 7, 2012

In Brief

A Phase 4 clinical trial evaluating Methadone and Buprenorphine/naloxone for Opiate Addiction. Completed, enrolled 54 participants across 2 sites.

Detailed Summary

The purpose of this study is to determine if buprenorphine or methadone is better for the treatment of chronic pain among patients who have become addicted to prescription narcotics.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpiate Addiction
CountriesUnited States
CollaboratorsNational Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Drug Abuse (NIDA)

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 13, 2009
Enrollment StartApr 1, 2009
Primary CompletionOct 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 17.2 years ago

Interventions

Methadonedrug

Oral, 10-60 mg per day, 2-4 times per day, 6 months

Buprenorphine/naloxonedrug

Sub-lingual, 4-16 mg per day, divided 2-4 times/day, 6 months